Targeting estrogen receptor increases progression-free survival in advanced breast cancer
Washington D.C.[USA], Oct. 9 : Fulvestrant significantly increases progression-free survival in women with positive advanced breast cancer, particularly those with less aggressive lower-volume disease, reports a recent research.Fulvestrant is a selecti…